Enterococcus Infection
Learn about Enterococcus infection (Enterococcal infection), including Enterococcus bacteremia and VRE infection. This resource provides information on diagnosis, treatment, and clinical documentation for healthcare professionals. Explore relevant medical coding terms and guidelines for accurate and efficient coding of Enterococcus infections.
Infection caused by Enterococcus bacteria, often resistant to antibiotics.
Fever, chills, fatigue, redness, swelling, pain at infection site. May cause UTI, wound infection, or sepsis.
Hospitals, nursing homes, healthcare facilities. Can occur after surgery or medical procedures.
ICD-10 Code Families
Complete code families applicable to A41.81
When to use each related code
| Description | When to use |
|---|---|
| Infection caused by Enterococcus bacteria. | Use for infections confirmed as caused by Enterococcus species. Consider specific species if known (e.g., E. faecalis). |
| Vancomycin-Resistant Enterococcus infection. | Use when Enterococcus infection shows resistance to vancomycin antibiotic. Specify vancomycin resistance level if known (e.g., VRE, VRSA). |
| Bacterial infection, unspecified. | Use when bacterial infection is present but the causative agent is unknown or not yet identified. Avoid if a more specific diagnosis is available. |
Best-practice checklist
- ✓Document site of Enterococcus infection (e.g., UTI, wound).
- ✓Specify if Vancomycin-Resistant Enterococcus (VRE).
- ✓Document symptoms (e.g., fever, chills, pain).
- ✓Note prior antibiotic use and sensitivities.
- ✓Include lab results confirming Enterococcus species.
Common pitfalls to avoid
Confusing enterococcus infection with sepsis or coding both when only one is clinically validated can lead to inaccurate DRG assignment.
Insufficient documentation of vancomycin resistance (VRE) can affect coding specificity and reimbursement. Clear VRE status is crucial.
Coding enterococcus infection without specifying the infection site (e.g., UTI, bloodstream) impacts data accuracy and severity reflection.
Best-practice tips
- 01Isolate patients with suspected VRE. Use contact precautions.
- 02Proper hand hygiene. Follow CDC guidelines for handwashing.
- 03Screen high-risk patients for VRE colonization. Rectal swabs.
- 04Judicious antibiotic use. Consult infectious disease specialist.
- 05Environmental cleaning. Disinfect surfaces to prevent transmission.
Step-by-step checklist
- 1
Confirm positive Enterococcus culture (ICD-10 A41.8, B95.2)
- 2
Review patient history for risk factors: recent hospitalization, indwelling devices, antibiotic use
- 3
Assess for signs/symptoms: fever, chills, redness, swelling, pain at infection site
- 4
Evaluate local susceptibility patterns for targeted antibiotic therapy (e.g., VRE screening)
- 5
Document infection source and severity for accurate coding and patient management
Ready-to-paste narrative
Patient presents with signs and symptoms suggestive of an Enterococcus infection. Presenting complaints include [specific patient complaints, e.g., fever, chills, urinary urgency, dysuria, abdominal pain, wound infection]. Physical examination revealed [relevant physical findings, e.g., tenderness at the surgical site, erythema, purulent drainage, costovertebral angle tenderness, altered mental status]. The patient's medical history includes [relevant medical history, e.g., recent surgery, indwelling catheter, diabetes mellitus, immunocompromised state]. Differential diagnoses considered include urinary tract infection, bacteremia, endocarditis, wound infection, intra-abdominal abscess, and other bacterial infections. Laboratory tests ordered include urine culture, blood culture, complete blood count (CBC) with differential, and procalcitonin. Preliminary findings suggest a possible Enterococcal infection, including the potential for Vancomycin-resistant Enterococcus (VRE). Empiric antibiotic therapy initiated with [antibiotic name and dosage] pending culture and sensitivity results. Patient will be monitored for response to treatment and potential complications such as sepsis, acute kidney injury, and endocarditis. Further investigations may include imaging studies such as ultrasound, CT scan, or echocardiogram based on clinical presentation and response to treatment. ICD-10 codes for consideration include [relevant ICD-10 codes, e.g., A41.89, B95.2]. Treatment plan will be adjusted based on culture and sensitivity results and clinical course. Patient education provided regarding infection prevention measures, medication compliance, and follow-up care.
Common questions and answers
What are the most effective treatment strategies for vancomycin-resistant Enterococcus faecium (VRE) bloodstream infections in critically ill patients?+
Vancomycin-resistant Enterococcus faecium (VRE) bloodstream infections in critically ill patients present a serious therapeutic challenge. Effective treatment strategies often involve a combination of antibiotics based on susceptibility testing. Linezolid and daptomycin are frequently employed, though newer agents like quinupristin-dalfopristin may be considered. Source control, such as removing infected catheters, is crucial. Furthermore, optimizing host factors, including adequate fluid resuscitation and electrolyte management, can improve patient outcomes. Explore how antibiotic stewardship programs can help minimize the emergence and spread of VRE. Consider implementing rapid diagnostic testing to guide appropriate antibiotic selection and reduce the risk of treatment failure. The Infectious Diseases Society of America (IDSA) guidelines offer further recommendations for managing VRE infections.
How can I differentiate Enterococcus faecalis from Enterococcus faecium in the clinical microbiology lab and what are the key distinctions in their antibiotic susceptibility profiles?+
Differentiating Enterococcus faecalis from Enterococcus faecium is vital for guiding appropriate antibiotic therapy. While both species can cause infections, they exhibit key differences in their antibiotic susceptibility. In the clinical microbiology lab, several methods can be employed. Biochemical tests, such as the ability to hydrolyze esculin in the presence of bile, can be utilized. E. faecalis is typically positive for this test, while E. faecium is usually negative. Molecular methods, like PCR, offer more definitive identification. E. faecium is more likely to exhibit resistance to multiple antibiotics, including vancomycin, making infections with this species more challenging to treat. E. faecalis, while often susceptible to ampicillin and vancomycin, may exhibit resistance to other agents. Learn more about the specific antibiotic resistance patterns of these two species to guide treatment decisions. Consider implementing rapid diagnostic testing in your lab to expedite species identification and susceptibility testing.
What are the recommended infection control measures to prevent the spread of vancomycin-resistant Enterococci (VRE) in hospital settings, particularly in intensive care units (ICUs)?+
Preventing the spread of vancomycin-resistant Enterococci (VRE) in hospital settings, especially ICUs, requires diligent infection control practices. Hand hygiene is paramount, with alcohol-based hand rubs being highly effective. Contact precautions, including the use of gloves and gowns when interacting with VRE-colonized or infected patients, are essential. Environmental cleaning and disinfection play a crucial role in minimizing VRE transmission. Cohorting VRE-positive patients can be considered in outbreak situations. Active surveillance cultures may be useful in high-risk units to identify colonized patients and implement appropriate isolation measures. Educating healthcare workers on VRE prevention strategies and ensuring compliance with these measures are critical for controlling the spread of this resistant organism. Explore how implementing a comprehensive VRE prevention bundle can improve patient safety and reduce healthcare-associated infections. Consider implementing antimicrobial stewardship programs to minimize the selective pressure that contributes to antibiotic resistance.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.